Chronic pain is a debilitating problem, and insights in the neurobiology of chronic pain are needed for the development of novel pain therapies. A genome-wide association study implicated the 5p15.2 region in chronic widespread pain. This region includes the coding region for FAM173B, a functionally uncharacterized protein. We demonstrate here that FAM173B is a mitochondrial lysine methyltransferase that promotes chronic pain. Knockdown and sensory neuron overexpression strategies showed that FAM173B is involved in persistent inflammatory and neuropathic pain via a pathway dependent on its methyltransferase activity. FAM173B methyltransferase activity in sensory neurons hyperpolarized mitochondria and promoted macrophage/microglia activation through a reactive oxygen species–dependent pathway. In summary, we uncover a role for methyltransferase activity of FAM173B in the neurobiology of pain. These results also highlight FAM173B methyltransferase activity as a potential therapeutic target to treat debilitating chronic pain conditions.
Identification of FAM173B as a protein methyltransferase promoting chronic pain
H. Willemen,A. Kavelaars,J. Prado,Mirjam Maas,S. Versteeg,Lara J J Nellissen,Jeshua Tromp,Rafael Gonzalez Cano,Wenjun Zhou,Magnus E. Jakobsson,J. Malecki,G. Posthuma,A. Habib,C. Heijnen,P. Falnes,N. Eijkelkamp
Published 2018 in PLoS Biology
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
PLoS Biology
- Publication date
2018-02-01
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-89 of 89 references · Page 1 of 1
CITED BY
Showing 1-30 of 30 citing papers · Page 1 of 1